liarozole has been researched along with calcitriol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aboraia, AS; Brancale, A; DeLuca, HF; Ferla, S; Ochalek, JT; Pepper, CJ; Simons, C; Zhu, J | 1 |
| Bouillon, R; Marcelis, S; Tan, BK; Verstuyf, A; Zhao, J | 1 |
| Feldman, D; Holloway, L; Ly, LH; Zhao, XY | 1 |
| Cui, M; Fleet, JC; Hance, KW; Shao, A; Wood, RJ; Zhao, Y | 1 |
4 other study(ies) available for liarozole and calcitriol
| Article | Year |
|---|---|
Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation.
Topics: Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Cytochrome P-450 Enzyme Inhibitors; Heme; Humans; Imidazoles; Inhibitory Concentration 50; Leukemia, Lymphocytic, Chronic, B-Cell; Models, Molecular; Sequence Homology, Amino Acid; Structure-Activity Relationship; Vitamin D3 24-Hydroxylase | 2014 |
Enhancement of antiproliferative activity of 1alpha,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific.
Topics: Calcitriol; Cell Division; Cytochrome P-450 Enzyme Inhibitors; Drug Synergism; Enzyme Inhibitors; Humans; Imidazoles; Ketoconazole; Tumor Cells, Cultured | 1996 |
Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Calcitriol; Cell Division; Drug Synergism; Enzyme Inhibitors; Half-Life; Humans; Imidazoles; Male; Prostatic Neoplasms; Receptors, Calcitriol; Tumor Cells, Cultured | 1999 |
Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2.
Topics: Caco-2 Cells; Calcitriol; Calcium; Calcium Channels; Enzyme Inhibitors; Epidermal Growth Factor; Gene Expression Regulation, Enzymologic; Humans; Imidazoles; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Promoter Regions, Genetic; Proto-Oncogene Protein c-ets-1; Receptors, Calcitriol; Retinoid X Receptor alpha; RNA Interference; Steroid Hydroxylases; TRPV Cation Channels; Two-Hybrid System Techniques; Vitamin D3 24-Hydroxylase; Vitamins | 2009 |